Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOPE Study
2024-513352-15-00Phase 2Authorised
- Sponsor
- Medical University of Vienna
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Portal Hypertension (PH) and decompensated cirrhosis comparing Norfloxacin with Placebo (2 arms). Planned start Dec 2024; status: authorised.
02
Drugs
norfloxacin
03
Conditions
Portal Hypertension (PH)decompensated cirrhosis
Beyond the preview
Go deeper on 2024-513352-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513352-15-00.